5 Key Takeaways

• 1

  Researchers have identified an epigenetic marker for prediabetes that can be measured through a single blood draw.

• 2

  The new approach utilizes DNA methylation profiling to distinguish between high- and low-risk individuals for diabetes.

• 3

  This method offers a more accessible and cost-effective alternative to traditional diabetes risk assessments.

• 4

  The epigenetic markers can predict future metabolic deterioration and complications associated with Type 2 diabetes.

• 5

  Future work aims to refine the epigenetic test for clinical use, making it practical and accessible for broader populations.